Cargando…
Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum
The missense mutation p.R406W in microtubule-associated protein tau leads to frontotemporal lobar degeneration with an amnestic, Alzheimer’s disease-like phenotype with an autosomal dominant pattern of inheritance. In 2003, we described the pedigree of a Belgian family, labelled ADG, with 28 p.R406W...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115352/ https://www.ncbi.nlm.nih.gov/pubmed/36171642 http://dx.doi.org/10.1093/brain/awac362 |
_version_ | 1785028194880978944 |
---|---|
author | Gossye, Helena Van Mossevelde, Sara Sieben, Anne Bjerke, Maria Hendrickx Van de Craen, Elisabeth van der Zee, Julie De Deyn, Peter P De Bleecker, Jan Versijpt, Jan van den Ende, Jenneke Deryck, Olivier Bourgeois, Paul Bier, Jean-Christophe Goethals, Maarten Vandenberghe, Rik Engelborghs, Sebastiaan Van Broeckhoven, Christine |
author_facet | Gossye, Helena Van Mossevelde, Sara Sieben, Anne Bjerke, Maria Hendrickx Van de Craen, Elisabeth van der Zee, Julie De Deyn, Peter P De Bleecker, Jan Versijpt, Jan van den Ende, Jenneke Deryck, Olivier Bourgeois, Paul Bier, Jean-Christophe Goethals, Maarten Vandenberghe, Rik Engelborghs, Sebastiaan Van Broeckhoven, Christine |
author_sort | Gossye, Helena |
collection | PubMed |
description | The missense mutation p.R406W in microtubule-associated protein tau leads to frontotemporal lobar degeneration with an amnestic, Alzheimer’s disease-like phenotype with an autosomal dominant pattern of inheritance. In 2003, we described the pedigree of a Belgian family, labelled ADG, with 28 p.R406W patients. Over 18 years follow-up, we extended the family with 10 p.R406W carriers and provided an in-depth clinical description of the patients. Additionally, genetic screening was used to identify p.R406W carriers in Belgian cohorts of frontotemporal dementia and Alzheimer’s disease patients and to calculate p.R406W frequency. In the frontotemporal dementia cohort, we found four p.R406W carriers (n = 647, 0.62%) and three in the Alzheimer’s disease cohort (n = 1134, 0.26%). Haplotype sharing analysis showed evidence of a shared haplotype suggesting that they are descendants of a common ancestor. Of the p.R406W patients, we describe characteristics of neuropsychological, imaging and fluid biomarkers as well as neuropathologic examination. Intriguingly, the phenotypic spectrum among the p.R406W patients ranged from typical behavioural variant frontotemporal dementia to clinical Alzheimer’s disease, based on CSF biomarker analysis and amyloid PET scan. Heterogeneous overlap syndromes existed in between, with highly common neuropsychiatric symptoms like disinhibition and aggressiveness, which occurred in 100% of frontotemporal dementia and 58% of clinical Alzheimer’s disease patients. This was also the case for memory problems, 89% in frontotemporal dementia and 100% in clinical Alzheimer’s disease patients. Median age at death was significantly lower in patients with frontotemporal dementia (68 years) compared to clinical Alzheimer’s disease patients (79 years), although the sizes of the sub-cohorts are limited and do not allow prognostic predictions. Post-mortem brain analysis of one p.R406W patient with behavioural variant frontotemporal dementia revealed frontotemporal lobar degeneration with tau pathology. Notably, neuropathological investigation showed only 3R tau isoforms in the absence of 4R tau reactivity, an unusual finding in microtubule-associated protein tau-related frontotemporal lobar degeneration. No traces of amyloid pathology were present. Prevalence of the p.R406W mutation was relatively high in both frontotemporal dementia and Alzheimer’s disease Belgian patient cohorts. These findings grant new insights into genotype–phenotype correlations of p.R406W carriers. They may help in further unravelling of the pathophysiology of this tauopathy and in facilitating the identification of patients with p.R406W-related frontotemporal lobar degeneration, both in clinical diagnostic and research settings. |
format | Online Article Text |
id | pubmed-10115352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101153522023-04-20 Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum Gossye, Helena Van Mossevelde, Sara Sieben, Anne Bjerke, Maria Hendrickx Van de Craen, Elisabeth van der Zee, Julie De Deyn, Peter P De Bleecker, Jan Versijpt, Jan van den Ende, Jenneke Deryck, Olivier Bourgeois, Paul Bier, Jean-Christophe Goethals, Maarten Vandenberghe, Rik Engelborghs, Sebastiaan Van Broeckhoven, Christine Brain Original Article The missense mutation p.R406W in microtubule-associated protein tau leads to frontotemporal lobar degeneration with an amnestic, Alzheimer’s disease-like phenotype with an autosomal dominant pattern of inheritance. In 2003, we described the pedigree of a Belgian family, labelled ADG, with 28 p.R406W patients. Over 18 years follow-up, we extended the family with 10 p.R406W carriers and provided an in-depth clinical description of the patients. Additionally, genetic screening was used to identify p.R406W carriers in Belgian cohorts of frontotemporal dementia and Alzheimer’s disease patients and to calculate p.R406W frequency. In the frontotemporal dementia cohort, we found four p.R406W carriers (n = 647, 0.62%) and three in the Alzheimer’s disease cohort (n = 1134, 0.26%). Haplotype sharing analysis showed evidence of a shared haplotype suggesting that they are descendants of a common ancestor. Of the p.R406W patients, we describe characteristics of neuropsychological, imaging and fluid biomarkers as well as neuropathologic examination. Intriguingly, the phenotypic spectrum among the p.R406W patients ranged from typical behavioural variant frontotemporal dementia to clinical Alzheimer’s disease, based on CSF biomarker analysis and amyloid PET scan. Heterogeneous overlap syndromes existed in between, with highly common neuropsychiatric symptoms like disinhibition and aggressiveness, which occurred in 100% of frontotemporal dementia and 58% of clinical Alzheimer’s disease patients. This was also the case for memory problems, 89% in frontotemporal dementia and 100% in clinical Alzheimer’s disease patients. Median age at death was significantly lower in patients with frontotemporal dementia (68 years) compared to clinical Alzheimer’s disease patients (79 years), although the sizes of the sub-cohorts are limited and do not allow prognostic predictions. Post-mortem brain analysis of one p.R406W patient with behavioural variant frontotemporal dementia revealed frontotemporal lobar degeneration with tau pathology. Notably, neuropathological investigation showed only 3R tau isoforms in the absence of 4R tau reactivity, an unusual finding in microtubule-associated protein tau-related frontotemporal lobar degeneration. No traces of amyloid pathology were present. Prevalence of the p.R406W mutation was relatively high in both frontotemporal dementia and Alzheimer’s disease Belgian patient cohorts. These findings grant new insights into genotype–phenotype correlations of p.R406W carriers. They may help in further unravelling of the pathophysiology of this tauopathy and in facilitating the identification of patients with p.R406W-related frontotemporal lobar degeneration, both in clinical diagnostic and research settings. Oxford University Press 2022-09-29 /pmc/articles/PMC10115352/ /pubmed/36171642 http://dx.doi.org/10.1093/brain/awac362 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Gossye, Helena Van Mossevelde, Sara Sieben, Anne Bjerke, Maria Hendrickx Van de Craen, Elisabeth van der Zee, Julie De Deyn, Peter P De Bleecker, Jan Versijpt, Jan van den Ende, Jenneke Deryck, Olivier Bourgeois, Paul Bier, Jean-Christophe Goethals, Maarten Vandenberghe, Rik Engelborghs, Sebastiaan Van Broeckhoven, Christine Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum |
title | Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum |
title_full | Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum |
title_fullStr | Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum |
title_full_unstemmed | Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum |
title_short | Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum |
title_sort | patients carrying the mutation p.r406w in mapt present with non-conforming phenotypic spectrum |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115352/ https://www.ncbi.nlm.nih.gov/pubmed/36171642 http://dx.doi.org/10.1093/brain/awac362 |
work_keys_str_mv | AT gossyehelena patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT vanmosseveldesara patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT siebenanne patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT bjerkemaria patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT hendrickxvandecraenelisabeth patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT vanderzeejulie patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT dedeynpeterp patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT debleeckerjan patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT versijptjan patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT vandenendejenneke patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT deryckolivier patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT bourgeoispaul patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT bierjeanchristophe patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT goethalsmaarten patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT vandenbergherik patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT engelborghssebastiaan patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum AT vanbroeckhovenchristine patientscarryingthemutationpr406winmaptpresentwithnonconformingphenotypicspectrum |